Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Macdonald

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
American Journal of Physiology. Renal Physiology|October 29, 2000
A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesionM D Okusa, J Linden, L Huang, et al.
Molecular Pharmacology|July 1, 1997
Structure/activity relationships in lysophosphatidic acid: the 2-hydroxyl moietyK R Lynch, D W Hopper, S J Carlisle, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2001
The synthesis of amino-acid functionalized beta-carbolines as topoisomerase II inhibitorsA M Deveau, M A Labroli, C M Dieckhaus, et al.
The Journal of Biological Chemistry|October 24, 2000
Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independentS B Hooks, W L Santos, D S Im, et al.
Journal of Medicinal Chemistry|May 24, 1996
Inhibition of DNA topoisomerase II by azaelliptitoxins functionalized in the variable substituent domainJ J Tepe, J S Madalengoitia, K M Slunt, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis and evaluation of benzannelated-azatoxins: the benzazatoxinsT A Miller, P R Vachaspati, M A Labroli, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2000
The synthesis, in vitro reactivity, and evidence for formation in humans of 5-phenyl-1,3-oxazinane-2,4-dione, a metabolite of felbamateC D Thompson, T A Miller, M T Barthen, et al.
Molecular Pharmacology|March 14, 1998
Characterization of a receptor subtype-selective lysophosphatidic acid mimeticS B Hooks, S P Ragan, D W Hopper, et al.
Molecular Pharmacology|November 28, 2001
Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonistC E Heise, W L Santos, A M Schreihofer, et al.
Chemical Research in Toxicology|September 26, 1997
A proposed mechanism for p-aminoclonidine allergenicity based on its relative oxidative labilityC D Thompson, P R Vachaspati, S P Kolis, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
American Journal of Physiology. Renal Physiology|October 29, 2000
A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesionM D Okusa, J Linden, L Huang, et al.
Molecular Pharmacology|July 1, 1997
Structure/activity relationships in lysophosphatidic acid: the 2-hydroxyl moietyK R Lynch, D W Hopper, S J Carlisle, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2001
The synthesis of amino-acid functionalized beta-carbolines as topoisomerase II inhibitorsA M Deveau, M A Labroli, C M Dieckhaus, et al.
The Journal of Biological Chemistry|October 24, 2000
Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independentS B Hooks, W L Santos, D S Im, et al.
Journal of Medicinal Chemistry|May 24, 1996
Inhibition of DNA topoisomerase II by azaelliptitoxins functionalized in the variable substituent domainJ J Tepe, J S Madalengoitia, K M Slunt, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis and evaluation of benzannelated-azatoxins: the benzazatoxinsT A Miller, P R Vachaspati, M A Labroli, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2000
The synthesis, in vitro reactivity, and evidence for formation in humans of 5-phenyl-1,3-oxazinane-2,4-dione, a metabolite of felbamateC D Thompson, T A Miller, M T Barthen, et al.
Molecular Pharmacology|March 14, 1998
Characterization of a receptor subtype-selective lysophosphatidic acid mimeticS B Hooks, S P Ragan, D W Hopper, et al.
Molecular Pharmacology|November 28, 2001
Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonistC E Heise, W L Santos, A M Schreihofer, et al.
Chemical Research in Toxicology|September 26, 1997
A proposed mechanism for p-aminoclonidine allergenicity based on its relative oxidative labilityC D Thompson, P R Vachaspati, S P Kolis, et al.
Pageof 7